Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02769975 · ClinicalTrials.gov registry record

Evaluation of Children With Endocrine and Metabolic-Related Conditions

A clinical trial of Metabolic Disease and Adrenal Insufficiency, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Recruiting
Registry status
15,000
Enrollment target
1
Study location

NCT02769975 is a study of Metabolic Disease and Adrenal Insufficiency that is actively recruiting participants, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 15,000 participants, above the 3,735-participant average among 33 other Metabolic Disease trials with a reported enrollment target (302% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02769975, a study of Metabolic Disease and Adrenal Insufficiency, is actively recruiting participants, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

RECRUITING
Registry status
15,000 participants
Enrollment target
1
Study location

Study Summary

Background: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes contain DNA, which is the blueprint of how a cell works. Researchers want to identify the genes involved in endocrine and metabolic disorders. This might help develop new ways to diagnose and treat the disorders. Objective: To study the inheritance of endocrine or metabolism disorders. Eligibility: Children ages 3month-18 with known or suspected endocrine or metabolism disorders. Family members ages 3months-100. They may participate in the DNA part of the study. Design: Participants will be screened with a review of their medical records. Their parents or guardians will allow the records to be released. Participants will have a clinic visit. This may include a physical exam and medical history. Parents or guardians will give their consent for the study. Participants may have tests, surgery, or other procedures to help diagnose or treat their condition. These could include: Blood, urine, and saliva tests Growth hormone test Pituitary and adrenal function tests Picture of chromosomes Imaging tests. These may include X-ray, ultrasound, scans, or a skeletal survey. Genetic tests Sleep study Medical photographs If surgery is done, a tissue sample will be taken. Participants may have follow-up visits for diagnosis and treatment. Participating relatives will have one visit. This will include medical history and blood and saliva tests. The blood and saliva will be used for DNA testing.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 15,000 participants
Start Date 2016-07-12
Est. Completion 2030-12-31

What the Registry Record Tells You About NCT02769975

The ClinicalTrials.gov registry entry for NCT02769975 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,735-participant average among 33 other Metabolic Disease trials with a reported enrollment target (302% higher). The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Metabolic Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02769975 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02769975 about?

NCT02769975 is a clinical study titled "Evaluation of Children With Endocrine and Metabolic-Related Conditions". Background: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes contain DNA, which is the blueprint of how a cell works. Researchers want to identify the genes involve...

What is the current status of trial NCT02769975?

This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2016-07-12. Estimated completion is 2030-12-31.

What conditions does trial NCT02769975 study?

This clinical trial studies the following conditions: Metabolic Disease, Adrenal Insufficiency, Bone Diseases, Metabolic, Endocrine Diseases, Growth Disorder.

Who is sponsoring clinical trial NCT02769975?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02769975 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.